Steven Cohen's TXG Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.85 M shares of 10x Genomics, Inc. (TXG) worth $71.04 M, representing 0.08% of the portfolio. First purchased in 2019-Q3, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in TXG, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 1.85 M shares. Largest reduction occurred in Q4 2024, reducing 1.23 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's 10x Genomics (TXG) Holding Value Over Time
Track share changes against reported price movement
Quarterly 10x Genomics (TXG) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +1.85 M | New Buy | 1.85 M | $38.34 |
| Q4 2024 | -1.23 M | Sold Out | 0 | $0.00 |
| Q3 2024 | +1.23 M | New Buy | 1.23 M | $22.58 |
| Q1 2024 | -497,282 | Sold Out | 0 | $0.00 |
| Q4 2023 | -850,137 | Reduce 63.09% | 497,282 | $55.96 |
| Q3 2023 | -255,749 | Reduce 15.95% | 1.35 M | $41.25 |
| Q2 2023 | +1.07 M | Add 198.91% | 1.6 M | $55.84 |
| Q1 2023 | +536,331 | New Buy | 536,331 | $55.79 |
| Q1 2022 | -171,462 | Sold Out | 0 | $0.00 |
| Q4 2021 | +171,462 | New Buy | 171,462 | $148.96 |
| Q2 2021 | -23,860 | Sold Out | 0 | $0.00 |
| Q1 2021 | -185,878 | Reduce 88.62% | 23,860 | $181.01 |
| Q4 2020 | +112,661 | Add 116.05% | 209,738 | $141.60 |
| Q3 2020 | +55,992 | Add 136.28% | 97,077 | $124.68 |
| Q2 2020 | -213,960 | Reduce 83.89% | 41,085 | $89.30 |
| Q1 2020 | +255,045 | New Buy | 255,045 | $62.32 |
| Q4 2019 | -400 | Sold Out | 0 | $0.00 |
| Q3 2019 | +400 | New Buy | 400 | $50.00 |
Steven Cohen's 10x Genomics Investment FAQs
Steven Cohen first purchased 10x Genomics, Inc. (TXG) in Q3 2019, acquiring 400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held 10x Genomics, Inc. (TXG) for 18 quarters since Q3 2019.
Steven Cohen's largest addition to 10x Genomics, Inc. (TXG) was in Q2 2026, adding 1,852,776 shares worth $71.04 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,852,776 shares of 10x Genomics, Inc. (TXG), valued at approximately $71.04 M.
As of the Q2 2026 filing, 10x Genomics, Inc. (TXG) represents approximately 0.08% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in 10x Genomics, Inc. (TXG) was 1,852,776 shares, as reported at the end of Q2 2026.